bioMerieux SA - Strategy, SWOT and Corporate Finance Report
Summary
bioMerieux SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
bioMerieux SA (bioMerieux or 'the company'), is a provider of diagnostic solutions for medical and industrial applications. These products are used to diagnose cardiovascular diseases, targeted cancers and infectious diseases and provides various vitro diagnostic solutions for hospitals. bioMerieux also offers sterility and quality testings for cosmetics, pharmaceutical and food sectors. The company also offers microbiology products, immunoassays, molecular biology tests, and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical and cosmetics industries; and veterinary diagnostic laboratories. It has operations across Europe, the Middle East and Africa, the Americas and Asia-Pacific. The company is headquartered in Marcy l'Etoile, Rhone Alpes, France.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook